IBDEI0DB ; ; 01-MAY-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 01, 2020
 Q:'DIFQR(358.4)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.4)
 ;;=^IBE(358.4,
 ;;^UTILITY(U,$J,358.4,0)
 ;;=IMP/EXP SELECTION GROUP^358.4I^1264^1264
 ;;^UTILITY(U,$J,358.4,1,0)
 ;;=OTPT-NEW PATIENT^2^1
 ;;^UTILITY(U,$J,358.4,2,0)
 ;;=OTPT-ESTABLISHED PATIENT^1^1
 ;;^UTILITY(U,$J,358.4,3,0)
 ;;=OTPT-CONSULTATIONS^3^1
 ;;^UTILITY(U,$J,358.4,4,0)
 ;;=INPT-INITIAL OBSERVATION^8^1
 ;;^UTILITY(U,$J,358.4,5,0)
 ;;=INPT-OBSERVATION DISCHARGE^9^1
 ;;^UTILITY(U,$J,358.4,6,0)
 ;;=INPT-BEDSIDE VISIT-INIT^4^1
 ;;^UTILITY(U,$J,358.4,7,0)
 ;;=INPT-BEDSIDE VISITS-DAILY^5^1
 ;;^UTILITY(U,$J,358.4,8,0)
 ;;=INPT-CONSULTATIONS^7^1
 ;;^UTILITY(U,$J,358.4,9,0)
 ;;=ADMIT & DISCHARGE SAME DAY^10^1
 ;;^UTILITY(U,$J,358.4,10,0)
 ;;=DISCHARGE DAY CODES^6^1
 ;;^UTILITY(U,$J,358.4,11,0)
 ;;=NEUROLOGY/SEIZURE/VNS PROGRAMMING^1^2
 ;;^UTILITY(U,$J,358.4,12,0)
 ;;=SEIZURES/EPILEPSY/SPELLS^1^3
 ;;^UTILITY(U,$J,358.4,13,0)
 ;;=CEREBROVASCULAR DISEASE^2^3
 ;;^UTILITY(U,$J,358.4,14,0)
 ;;=DIZZINESS^3^3
 ;;^UTILITY(U,$J,358.4,15,0)
 ;;=ENCEPHALOPATHY^4^3
 ;;^UTILITY(U,$J,358.4,16,0)
 ;;=HEADACHE^5^3
 ;;^UTILITY(U,$J,358.4,17,0)
 ;;=MOVEMENT DISORDERS^6^3
 ;;^UTILITY(U,$J,358.4,18,0)
 ;;=NEOPLASMS^7^3
 ;;^UTILITY(U,$J,358.4,19,0)
 ;;=NEURODEGENERATIVE DISEASE^8^3
 ;;^UTILITY(U,$J,358.4,20,0)
 ;;=SLEEP DISORDERS^9^3
 ;;^UTILITY(U,$J,358.4,21,0)
 ;;=SPECIAL SCREENING^10^3
 ;;^UTILITY(U,$J,358.4,22,0)
 ;;=OTHER^11^3
 ;;^UTILITY(U,$J,358.4,23,0)
 ;;=MD/NP/PA^1^4
 ;;^UTILITY(U,$J,358.4,24,0)
 ;;=NON-LIP^2^4
 ;;^UTILITY(U,$J,358.4,25,0)
 ;;=SEIZURES/EPILEPSY/SPELLS^1^5
 ;;^UTILITY(U,$J,358.4,26,0)
 ;;=CEREBROVASCULAR DISEASE^2^5
 ;;^UTILITY(U,$J,358.4,27,0)
 ;;=DIZZINESS^3^5
 ;;^UTILITY(U,$J,358.4,28,0)
 ;;=ENCEPHALOPATHY^4^5
 ;;^UTILITY(U,$J,358.4,29,0)
 ;;=HEADACHE^5^5
 ;;^UTILITY(U,$J,358.4,30,0)
 ;;=MOVEMENT DISORDERS^6^5
 ;;^UTILITY(U,$J,358.4,31,0)
 ;;=NEOPLASMS^7^5
 ;;^UTILITY(U,$J,358.4,32,0)
 ;;=NEURODEGENERATIVE DISEASE^8^5
 ;;^UTILITY(U,$J,358.4,33,0)
 ;;=SLEEP DISORDERS^9^5
 ;;^UTILITY(U,$J,358.4,34,0)
 ;;=SPECIAL SCREENING^10^5
 ;;^UTILITY(U,$J,358.4,35,0)
 ;;=OTHER^11^5
 ;;^UTILITY(U,$J,358.4,36,0)
 ;;=EEG LTM^1^6
 ;;^UTILITY(U,$J,358.4,37,0)
 ;;=EEG PROCEDURAL^3^6
 ;;^UTILITY(U,$J,358.4,38,0)
 ;;=EEG ROUTINE^4^6
 ;;^UTILITY(U,$J,358.4,39,0)
 ;;=INTRAOPERATIVE EVOKED POTENTIALS^5^6
 ;;^UTILITY(U,$J,358.4,40,0)
 ;;=NEUROLOGY/SEIZURE/VNS PROGRAMMING^6^6
 ;;^UTILITY(U,$J,358.4,41,0)
 ;;=EEG MONITORING^2^6
 ;;^UTILITY(U,$J,358.4,42,0)
 ;;=SEIZURES/EPILEPSY/SPELLS^1^7
 ;;^UTILITY(U,$J,358.4,43,0)
 ;;=CEREBROVASCULAR DISEASE^2^7
 ;;^UTILITY(U,$J,358.4,44,0)
 ;;=DIZZINESS^3^7
 ;;^UTILITY(U,$J,358.4,45,0)
 ;;=ENCEPHALOPATHY^4^7
 ;;^UTILITY(U,$J,358.4,46,0)
 ;;=HEADACHE^5^7
 ;;^UTILITY(U,$J,358.4,47,0)
 ;;=MOVEMENT DISORDERS^6^7
 ;;^UTILITY(U,$J,358.4,48,0)
 ;;=NEOPLASMS^7^7
 ;;^UTILITY(U,$J,358.4,49,0)
 ;;=NEURODEGENERATIVE DISEASE^8^7
 ;;^UTILITY(U,$J,358.4,50,0)
 ;;=SLEEP DISORDERS^9^7
 ;;^UTILITY(U,$J,358.4,51,0)
 ;;=SPECIAL SCREENING^10^7
 ;;^UTILITY(U,$J,358.4,52,0)
 ;;=OTHER^11^7
 ;;^UTILITY(U,$J,358.4,53,0)
 ;;=PHYSICIAN TELEPHONE CODES^1^8
 ;;^UTILITY(U,$J,358.4,54,0)
 ;;=NON-PHYSICIAN TELEPHONE CALLS^2^8
 ;;^UTILITY(U,$J,358.4,55,0)
 ;;=INTERPROFESSIONAL/INTERNET CONSULT^3^8
 ;;^UTILITY(U,$J,358.4,56,0)
 ;;=SEIZURES/EPILEPSY/SPELLS^1^9
 ;;^UTILITY(U,$J,358.4,57,0)
 ;;=CEREBROVASCULAR DISEASE^2^9
 ;;^UTILITY(U,$J,358.4,58,0)
 ;;=DIZZINESS^3^9
 ;;^UTILITY(U,$J,358.4,59,0)
 ;;=ENCEPHALOPATHY^4^9
 ;;^UTILITY(U,$J,358.4,60,0)
 ;;=HEADACHE^5^9
 ;;^UTILITY(U,$J,358.4,61,0)
 ;;=MOVEMENT DISORDERS^6^9
 ;;^UTILITY(U,$J,358.4,62,0)
 ;;=NEOPLASMS^7^9
 ;;^UTILITY(U,$J,358.4,63,0)
 ;;=NEURODEGENERATIVE DISEASE^8^9
 ;;^UTILITY(U,$J,358.4,64,0)
 ;;=SLEEP DISORDERS^9^9
 ;;^UTILITY(U,$J,358.4,65,0)
 ;;=SPECIAL SCREENING^10^9
 ;;^UTILITY(U,$J,358.4,66,0)
 ;;=OTHER^11^9
 ;;^UTILITY(U,$J,358.4,67,0)
 ;;=SPECIAL SERVICES^6^10
 ;;^UTILITY(U,$J,358.4,68,0)
 ;;=TREATMENT^7^10
 ;;^UTILITY(U,$J,358.4,69,0)
 ;;=MISCELLANEOUS^4^10
 ;;^UTILITY(U,$J,358.4,70,0)
 ;;=IMMUNIZATIONS^3^10
 ;;^UTILITY(U,$J,358.4,71,0)
 ;;=CHEMO ADMINISTRATION^1^10
 ;;^UTILITY(U,$J,358.4,72,0)
 ;;=CHEMO DRUGS^2^10
 ;;^UTILITY(U,$J,358.4,73,0)
 ;;=OTHER DRUGS^5^10
 ;;^UTILITY(U,$J,358.4,74,0)
 ;;=NEW PATIENT^2^11
 ;;^UTILITY(U,$J,358.4,75,0)
 ;;=ESTABLISHED PATIENT^1^11
 ;;^UTILITY(U,$J,358.4,76,0)
 ;;=CONSULTATIONS^3^11
 ;;^UTILITY(U,$J,358.4,77,0)
 ;;=POST OP^4^11
 ;;^UTILITY(U,$J,358.4,78,0)
 ;;=ANEMIA^2^12
 ;;^UTILITY(U,$J,358.4,79,0)
 ;;=BREAST & GYN NEOPLASMS^2^12
 ;;^UTILITY(U,$J,358.4,80,0)
 ;;=COAGULATION DISORDERS^3^12
 ;;^UTILITY(U,$J,358.4,81,0)
 ;;=COUNSELING & SCREENING^4^12
 ;;^UTILITY(U,$J,358.4,82,0)
 ;;=GENITOURINARY NEOPLASMS^5^12
 ;;^UTILITY(U,$J,358.4,83,0)
 ;;=GI CANCER^6^12
 ;;^UTILITY(U,$J,358.4,84,0)
 ;;=HEAD/NECK/LUNG CANCER^7^12
 ;;^UTILITY(U,$J,358.4,85,0)
 ;;=HEMOGLOBINOPATHIES^9^12
 ;;^UTILITY(U,$J,358.4,86,0)
 ;;=LYMPHOID NEOPLASMS^10^12
 ;;^UTILITY(U,$J,358.4,87,0)
 ;;=METASTATIC SITES^11^12
 ;;^UTILITY(U,$J,358.4,88,0)
 ;;=MISC. NEOPLASMS^12^12
 ;;^UTILITY(U,$J,358.4,89,0)
 ;;=MYELOID NEOPLASMS/DISORDERS^13^12
 ;;^UTILITY(U,$J,358.4,90,0)
 ;;=PERSONAL HX OF CANCER^15^12
 ;;^UTILITY(U,$J,358.4,91,0)
 ;;=OTHER^14^12
 ;;^UTILITY(U,$J,358.4,92,0)
 ;;=HEMATOLOGICAL^8^12
 ;;^UTILITY(U,$J,358.4,93,0)
 ;;=SYMPTOMS^17^12
 ;;^UTILITY(U,$J,358.4,94,0)
 ;;=TREATMENT^18^12
 ;;^UTILITY(U,$J,358.4,95,0)
 ;;=SUICIDE IDEATIONS/ATTEMPTS^16^12
 ;;^UTILITY(U,$J,358.4,96,0)
 ;;=ABNORMAL LAB TEST RESULTS^1^12
 ;;^UTILITY(U,$J,358.4,97,0)
 ;;=ESTABLISHED PATIENT^2^13
 ;;^UTILITY(U,$J,358.4,98,0)
 ;;=WORK/DISABILITY^1^13
 ;;^UTILITY(U,$J,358.4,99,0)
 ;;=NEW PATIENT^3^13
 ;;^UTILITY(U,$J,358.4,100,0)
 ;;=IMMUNIZATION^3^14
 ;;^UTILITY(U,$J,358.4,101,0)
 ;;=SKIN TEST^10^14
 ;;^UTILITY(U,$J,358.4,102,0)
 ;;=LACERATION REPAIR/SUTURES^4^14
 ;;^UTILITY(U,$J,358.4,103,0)
 ;;=OTHER^5^14
 ;;^UTILITY(U,$J,358.4,104,0)
 ;;=FOREIGN BODY REMOVAL^1^14
 ;;^UTILITY(U,$J,358.4,105,0)
 ;;=PREVENTIVE MEDICINE-EST PT^6^14
 ;;^UTILITY(U,$J,358.4,106,0)
 ;;=PREVENTIVE MEDICINE-NEW PT^7^14
 ;;^UTILITY(U,$J,358.4,107,0)
 ;;=SCREENING RESULTS^9^14
 ;;^UTILITY(U,$J,358.4,108,0)
 ;;=PROLONGED CLINICAL STAFF TIME^8^14
 ;;^UTILITY(U,$J,358.4,109,0)
 ;;=IMMUNIZATION ADMIN^2^14
 ;;^UTILITY(U,$J,358.4,110,0)
 ;;=INJURIES^6^15
 ;;^UTILITY(U,$J,358.4,111,0)
 ;;=EMPLOYEE HEALTH COMMON DX^1^15
 ;;^UTILITY(U,$J,358.4,112,0)
 ;;=EXAMINATIONS^3^15
 ;;^UTILITY(U,$J,358.4,113,0)
 ;;=EXPOSURES^4^15
 ;;^UTILITY(U,$J,358.4,114,0)
 ;;=IMMUNIZATIONS^5^15
 ;;^UTILITY(U,$J,358.4,115,0)
 ;;=COUNSELING^2^15
 ;;^UTILITY(U,$J,358.4,116,0)
 ;;=MUSCLE CONDITIONING EXERCISE^7^15
 ;;^UTILITY(U,$J,358.4,117,0)
 ;;=SUICIDE IDEATIONS/ATTEMPTS^8^15
 ;;^UTILITY(U,$J,358.4,118,0)
 ;;=ESTABLISHED PATIENT^1^16
 ;;^UTILITY(U,$J,358.4,119,0)
 ;;=CONSULTATIONS/OPINIONS^2^16
 ;;^UTILITY(U,$J,358.4,120,0)
 ;;=NEW PATIENTS^3^16
 ;;^UTILITY(U,$J,358.4,121,0)
 ;;=NEUROLOGY/SEIZURE^7^17
 ;;^UTILITY(U,$J,358.4,122,0)
 ;;=EEG^4^17
 ;;^UTILITY(U,$J,358.4,123,0)
 ;;=SLEEP TESTING^9^17
 ;;^UTILITY(U,$J,358.4,124,0)
 ;;=MUSCLE TESTING/EMG^6^17
 ;;^UTILITY(U,$J,358.4,125,0)
 ;;=EVOKED POTENTIAL^5^17
 ;;^UTILITY(U,$J,358.4,126,0)
 ;;=BIOPSY^2^17
 ;;^UTILITY(U,$J,358.4,127,0)
 ;;=AUTONOMIC FUNCTION TESTS^1^17
 ;;^UTILITY(U,$J,358.4,128,0)
 ;;=STEREOTACTIC^10^17
 ;;^UTILITY(U,$J,358.4,129,0)
 ;;=EDUCATION^3^17
 ;;^UTILITY(U,$J,358.4,130,0)
 ;;=NEUROSTIMULATORS^8^17
 ;;^UTILITY(U,$J,358.4,131,0)
 ;;=SEIZURES/EPILEPSY/SPELLS^15^18
 ;;^UTILITY(U,$J,358.4,132,0)
 ;;=CEREBROVASCULAR DISEASE^2^18
 ;;^UTILITY(U,$J,358.4,133,0)
 ;;=DIZZINESS^3^18
 ;;^UTILITY(U,$J,358.4,134,0)
 ;;=ENCEPHALOPATHY^5^18
 ;;^UTILITY(U,$J,358.4,135,0)
 ;;=HEADACHE^6^18
 ;;^UTILITY(U,$J,358.4,136,0)
 ;;=MOVEMENT DISORDERS^8^18
 ;;^UTILITY(U,$J,358.4,137,0)
 ;;=NEOPLASMS^10^18
 ;;^UTILITY(U,$J,358.4,138,0)
 ;;=NEURODEGENERATIVE DISEASE^11^18
 ;;^UTILITY(U,$J,358.4,139,0)
 ;;=OTHER^13^18
 ;;^UTILITY(U,$J,358.4,140,0)
 ;;=CARDIAC DISORDERS^1^18
 ;;^UTILITY(U,$J,358.4,141,0)
 ;;=INFLAMMATORY & DEMYELINATING DISEASES^7^18
 ;;^UTILITY(U,$J,358.4,142,0)
 ;;=NEUROMUSCULAR DISORDERS^12^18
 ;;^UTILITY(U,$J,358.4,143,0)
 ;;=PAIN^14^18
 ;;^UTILITY(U,$J,358.4,144,0)
 ;;=SPINAL CONDITIONS^16^18
 ;;^UTILITY(U,$J,358.4,145,0)
 ;;=SYMPTOMS^18^18
 ;;^UTILITY(U,$J,358.4,146,0)
 ;;=VISION DISTURBANCES^19^18
 ;;^UTILITY(U,$J,358.4,147,0)
 ;;=EMG DX^4^18
 ;;^UTILITY(U,$J,358.4,148,0)
 ;;=SUICIDE IDEATIONS/ATTEMPTS^17^18
 ;;^UTILITY(U,$J,358.4,149,0)
 ;;=MUSCLE ATROPHY^9^18
 ;;^UTILITY(U,$J,358.4,150,0)
 ;;=AUDIOLOGIC FUNCTION TESTS^1^19
 ;;^UTILITY(U,$J,358.4,151,0)
 ;;=SCREENING^12^19
 ;;^UTILITY(U,$J,358.4,152,0)
 ;;=COCHLEAR IMPLANT^2^19
 ;;^UTILITY(U,$J,358.4,153,0)
 ;;=OTHER TREATMENT^9^19
 ;;^UTILITY(U,$J,358.4,154,0)
 ;;=DISPENSING^4^19
 ;;^UTILITY(U,$J,358.4,155,0)
 ;;=REMOVAL FOREIGN BODY/CERUMEN^11^19
 ;;^UTILITY(U,$J,358.4,156,0)
 ;;=VESTIBULAR FUNCT W/ RECORDING^14^19
 ;;^UTILITY(U,$J,358.4,157,0)
 ;;=VESTIBULAR FUNCT W/O RECORDING^15^19
 ;;^UTILITY(U,$J,358.4,158,0)
 ;;=EVALUATIVE & THERAPEUTIC SVCS^5^19
 ;;^UTILITY(U,$J,358.4,159,0)
 ;;=TEAM CONFERENCE^13^19
 ;;^UTILITY(U,$J,358.4,160,0)
 ;;=PROLONGED CLINICAL STAFF SERVICES^10^19
 ;;^UTILITY(U,$J,358.4,161,0)
 ;;=OTHER SERVICES^8^19
 ;;^UTILITY(U,$J,358.4,162,0)
 ;;=DEVICES & EQUIPMENT^3^19
 ;;^UTILITY(U,$J,358.4,163,0)
 ;;=EXCISION^6^19
 ;;^UTILITY(U,$J,358.4,164,0)
 ;;=INCISION^7^19
 ;;^UTILITY(U,$J,358.4,165,0)
 ;;=ACOUSTIC NERVE INJURIES^1^20
 ;;^UTILITY(U,$J,358.4,166,0)
 ;;=AUDITORY DISORDERS^2^20
 ;;^UTILITY(U,$J,358.4,167,0)
 ;;=BALANCE DISORDERS^3^20
 ;;^UTILITY(U,$J,358.4,168,0)
 ;;=BAROTRAUMA^4^20
 ;;^UTILITY(U,$J,358.4,169,0)
 ;;=EAR DISEASE^5^20
 ;;^UTILITY(U,$J,358.4,170,0)
 ;;=FOREIGN BODIES^7^20
 ;;^UTILITY(U,$J,358.4,171,0)
 ;;=HEARING LOSS^8^20
 ;;^UTILITY(U,$J,358.4,172,0)
 ;;=NOISE INJURIES^9^20
 ;;^UTILITY(U,$J,358.4,173,0)
 ;;=NYSTAGMUS^10^20
 ;;^UTILITY(U,$J,358.4,174,0)
 ;;=OTOTOXICITY^11^20
 ;;^UTILITY(U,$J,358.4,175,0)
 ;;=PURPOSE OF ENCOUNTER/HEALTH STATUS^12^20
 ;;^UTILITY(U,$J,358.4,176,0)
 ;;=EXTERNAL EAR DISEASES^6^20
 ;;^UTILITY(U,$J,358.4,177,0)
 ;;=NEW PATIENT^2^21
 ;;^UTILITY(U,$J,358.4,178,0)
 ;;=ESTABLISHED PATIENT^1^21
 ;;^UTILITY(U,$J,358.4,179,0)
 ;;=CONSULTATIONS^3^21
 ;;^UTILITY(U,$J,358.4,180,0)
 ;;=ASSESSMENT/COUNSELING^1^22
 ;;^UTILITY(U,$J,358.4,181,0)
 ;;=ONE ON ONE TRAINING^6^22
 ;;^UTILITY(U,$J,358.4,182,0)
 ;;=ED/GRP/FAMILY TRNG FOR SELF MGMT^2^22
 ;;^UTILITY(U,$J,358.4,183,0)
 ;;=TEAM CONFERENCE^8^22
 ;;^UTILITY(U,$J,358.4,184,0)
 ;;=HOME VISIT^5^22
 ;;^UTILITY(U,$J,358.4,185,0)
 ;;=IMPAIRMENT CODES^1^23
 ;;^UTILITY(U,$J,358.4,186,0)
 ;;=CONTRIBUTORY CONDITION^2^23
 ;;^UTILITY(U,$J,358.4,187,0)
 ;;=TBI-RELATED CONTRIB COND^5^23
 ;;^UTILITY(U,$J,358.4,188,0)
 ;;=SUICIDE IDEATIONS/ATTEMPTS^4^23
 ;;^UTILITY(U,$J,358.4,189,0)
 ;;=FAMILY HX EYE CONDITIONS^3^23
 ;;^UTILITY(U,$J,358.4,190,0)
 ;;=NEW PATIENT^2^24
 ;;^UTILITY(U,$J,358.4,191,0)
 ;;=ESTABLISHED PATIENT^1^24
 ;;^UTILITY(U,$J,358.4,192,0)
 ;;=CONSULTATIONS^3^24
 ;;^UTILITY(U,$J,358.4,193,0)
 ;;=MISCELLANEOUS TREATMENT^4^25
 ;;^UTILITY(U,$J,358.4,194,0)
 ;;=CHIROPRACTIC MANIPULATIVE SERVICES^2^25
 ;;^UTILITY(U,$J,358.4,195,0)
 ;;=OSTEOPATHIC MANIPULATIVE TREATMENT^5^25
 ;;^UTILITY(U,$J,358.4,196,0)
 ;;=ACUPUNCTURE^1^25
 ;;^UTILITY(U,$J,358.4,197,0)
 ;;=EDUCATION FOR SELF MGT^3^25
 ;;^UTILITY(U,$J,358.4,198,0)
 ;;=EXTREMITIES/JOINTS/MUSCLES^6^26
 ;;^UTILITY(U,$J,358.4,199,0)
 ;;=HEAD AREA/NERVES^1^26
 ;;^UTILITY(U,$J,358.4,200,0)
 ;;=CERVICAL^2^26
 ;;^UTILITY(U,$J,358.4,201,0)
 ;;=THORACIC^3^26
 ;;^UTILITY(U,$J,358.4,202,0)
 ;;=LUMBAR^4^26
 ;;^UTILITY(U,$J,358.4,203,0)
 ;;=SACRUM^5^26
 ;;^UTILITY(U,$J,358.4,204,0)
 ;;=UNSPECIFIED^7^26
 ;;^UTILITY(U,$J,358.4,205,0)
 ;;=COUNSELING/EDUCATION^5^27
 ;;^UTILITY(U,$J,358.4,206,0)
 ;;=PSYCHIATRIC THERAPY^10^27
 ;;^UTILITY(U,$J,358.4,207,0)
 ;;=BIOFEEDBACK THERAPY^2^27
 ;;^UTILITY(U,$J,358.4,208,0)
 ;;=BIOPSYCHOSOCIAL ASSESS/INTERVENTION^3^27
 ;;^UTILITY(U,$J,358.4,209,0)
 ;;=PHYSICAL THERAPY^9^27
 ;;^UTILITY(U,$J,358.4,210,0)
 ;;=OTHER THERAPEUTIC TECHNIQUES^8^27
 ;;^UTILITY(U,$J,358.4,211,0)
 ;;=ACUPUNTURE^1^27
 ;;^UTILITY(U,$J,358.4,212,0)
 ;;=OSTEOPATHIC MANIPULATION^7^27
 ;;^UTILITY(U,$J,358.4,213,0)
 ;;=CHIROPRACTIC MANIPULATION^4^27
 ;;^UTILITY(U,$J,358.4,214,0)
 ;;=SELF-MANAGEMENT TRAINING^11^27
 ;;^UTILITY(U,$J,358.4,215,0)
 ;;=NUTRITION APPROACHES^6^27
 ;;^UTILITY(U,$J,358.4,216,0)
 ;;=COUNSELING^2^28
 ;;^UTILITY(U,$J,358.4,217,0)
 ;;=HISTORY OF ILLNESS^7^28
 ;;^UTILITY(U,$J,358.4,218,0)
 ;;=OTHER^19^28
 ;;^UTILITY(U,$J,358.4,219,0)
 ;;=SCREENING^14^28
 ;;^UTILITY(U,$J,358.4,220,0)
 ;;=CARDIOVASCULAR DISORDER^1^28
 ;;^UTILITY(U,$J,358.4,221,0)
 ;;=DIABETIC MANAGEMENT^3^28
 ;;^UTILITY(U,$J,358.4,222,0)
 ;;=ENDOCRINE DISORDER^4^28
 ;;^UTILITY(U,$J,358.4,223,0)
 ;;=HEARING DISORDER^6^28
 ;;^UTILITY(U,$J,358.4,224,0)
 ;;=GASTROINTESTINAL DISORDER^5^28
 ;;^UTILITY(U,$J,358.4,225,0)
 ;;=INJURIES^8^28
 ;;^UTILITY(U,$J,358.4,226,0)
 ;;=NEOPLASM^11^28
 ;;^UTILITY(U,$J,358.4,227,0)
 ;;=RESPIRATORY DISORDER^13^28
 ;;^UTILITY(U,$J,358.4,228,0)
 ;;=SIGNS AND SYMPTOMS^15^28
 ;;^UTILITY(U,$J,358.4,229,0)
 ;;=SUBSTANCE DISORDERS^16^28
 ;;^UTILITY(U,$J,358.4,230,0)
 ;;=WEIGHT MANAGEMENT^18^28
 ;;^UTILITY(U,$J,358.4,231,0)
 ;;=MOOD DISORDER^9^28
 ;;^UTILITY(U,$J,358.4,232,0)
 ;;=MUSCULOSKELETAL DISORDER^10^28
 ;;^UTILITY(U,$J,358.4,233,0)
 ;;=NEUROLOGICAL^12^28
 ;;^UTILITY(U,$J,358.4,234,0)
 ;;=SUICIDE IDEATIONS/ATTEMPTS^17^28
 ;;^UTILITY(U,$J,358.4,235,0)
 ;;=ESTABLISHED PATIENT^1^29
 ;;^UTILITY(U,$J,358.4,236,0)
 ;;=NEW PATIENT^2^29
 ;;^UTILITY(U,$J,358.4,237,0)
 ;;=NEW PATIENT^3^31
 ;;^UTILITY(U,$J,358.4,238,0)
 ;;=ESTABLISHED PATIENT^2^31
 ;;^UTILITY(U,$J,358.4,239,0)
 ;;=CONSULTATIONS^4^31
 ;;^UTILITY(U,$J,358.4,240,0)
 ;;=PROVIDER WEEKLY VISIT^1^31
 ;;^UTILITY(U,$J,358.4,241,0)
 ;;=ACCESS^5^32
 ;;^UTILITY(U,$J,358.4,242,0)
 ;;=DIALYSIS PROCEDURES^6^32
 ;;^UTILITY(U,$J,358.4,243,0)
 ;;=ESRD HOME SERVICES^7^32
 ;;^UTILITY(U,$J,358.4,244,0)
 ;;=HEMODIALYSIS OVERSIGHT^1^32
 ;;^UTILITY(U,$J,358.4,245,0)
 ;;=LAB^9^32
 ;;^UTILITY(U,$J,358.4,246,0)
 ;;=MEDICATIONS^10^32
 ;;^UTILITY(U,$J,358.4,247,0)
 ;;=MONITORING^11^32
 ;;^UTILITY(U,$J,358.4,248,0)
 ;;=OTHER^12^32
 ;;^UTILITY(U,$J,358.4,249,0)
 ;;=PATIENT EDUCATION/TEACHING^13^32
 ;;^UTILITY(U,$J,358.4,250,0)
 ;;=PATIENT MANAGEMENT^14^32
 ;;^UTILITY(U,$J,358.4,251,0)
 ;;=SUPPLIES^15^32
 ;;^UTILITY(U,$J,358.4,252,0)
 ;;=VACCINATIONS^16^32
 ;;^UTILITY(U,$J,358.4,253,0)
 ;;=DAILY DIALYSIS TXMT^2^32
 ;;^UTILITY(U,$J,358.4,254,0)
 ;;=INPATIENT DIALYSIS^8^32
 ;;^UTILITY(U,$J,358.4,255,0)
 ;;=PERITONEAL DIALYSIS^3^32
 ;;^UTILITY(U,$J,358.4,256,0)
 ;;=TEAM CONFERENCE^4^32
 ;;^UTILITY(U,$J,358.4,257,0)
 ;;=HEMODIALYSIS-ESRD^14^33
 ;;^UTILITY(U,$J,358.4,258,0)
 ;;=PERITONEAL DIALYSIS ENCOUNTER^23^33
 ;;^UTILITY(U,$J,358.4,259,0)
 ;;=CARDIOLOGY/CARDIORENAL SYNDROME^2^33
 ;;^UTILITY(U,$J,358.4,260,0)
 ;;=COMPLICATIONS/OTHER^4^33
 ;;^UTILITY(U,$J,358.4,261,0)
 ;;=CYSTIC KIDNEY DISEASE^5^33
 ;;^UTILITY(U,$J,358.4,262,0)
 ;;=DIABETES/DIABETIC RENAL DISEASE^6^33
 ;;^UTILITY(U,$J,358.4,263,0)
 ;;=FLUID/ELECTROLYTE DISORDER^8^33
 ;;^UTILITY(U,$J,358.4,264,0)
 ;;=GENERAL SYMPTOMS^9^33
 ;;^UTILITY(U,$J,358.4,265,0)
 ;;=GENITAL/URINARY^10^33
 ;;^UTILITY(U,$J,358.4,266,0)
 ;;=HEMATOLOGY^12^33
 ;;^UTILITY(U,$J,358.4,267,0)
 ;;=HYPERTENSION^15^33
 ;;^UTILITY(U,$J,358.4,268,0)
 ;;=INFECTIOUS DISEASE^16^33
 ;;^UTILITY(U,$J,358.4,269,0)
 ;;=NEPHRITIS GLUMERULONEPHRITIS^18^33
 ;;^UTILITY(U,$J,358.4,270,0)
 ;;=NEPHRITIS INTERSTITIAL^19^33
 ;;^UTILITY(U,$J,358.4,271,0)
 ;;=NEPHROTIC SYNDROME^21^33
 ;;^UTILITY(U,$J,358.4,272,0)
 ;;=OBSTRUCTIVE UROPATHY^22^33
 ;;^UTILITY(U,$J,358.4,273,0)
 ;;=TRANSPLANT^26^33
 ;;^UTILITY(U,$J,358.4,274,0)
 ;;=CKD/KIDNEY DISEASE^3^33
 ;;^UTILITY(U,$J,358.4,275,0)
 ;;=HEMODIALYSIS-AKI^13^33
 ;;^UTILITY(U,$J,358.4,276,0)
 ;;=ACUTE KIDNEY INJURY^1^33
 ;;^UTILITY(U,$J,358.4,277,0)
 ;;=GLOMERULAR DISEASE^11^33
 ;;^UTILITY(U,$J,358.4,278,0)
 ;;=KIDNEY INVOLVMNT IN SYSTEMIC DISEASE^17^33
 ;;^UTILITY(U,$J,358.4,279,0)
 ;;=NEPHROLITHASIS^20^33
 ;;^UTILITY(U,$J,358.4,280,0)
 ;;=POISONING & INTOXICATIONS^24^33
 ;;^UTILITY(U,$J,358.4,281,0)
 ;;=DIALYSIS^7^33
 ;;^UTILITY(U,$J,358.4,282,0)
 ;;=SUICIDE IDEATIONS/ATTEMPTS^25^33
 ;;^UTILITY(U,$J,358.4,283,0)
 ;;=ACUTE RENAL FAILURE^1^34
 ;;^UTILITY(U,$J,358.4,284,0)
 ;;=CARDIOVASCULAR^2^34
 ;;^UTILITY(U,$J,358.4,285,0)
 ;;=CHRONIC KIDNEY DISEASE^3^34
 ;;^UTILITY(U,$J,358.4,286,0)
 ;;=CONTACT/EXPOSURE TO COM D^4^34
 ;;^UTILITY(U,$J,358.4,287,0)
 ;;=DERMATOLOGY^5^34
 ;;^UTILITY(U,$J,358.4,288,0)
 ;;=DIABETES W/ COMPLICATIONS^6^34
 ;;^UTILITY(U,$J,358.4,289,0)
 ;;=DIABETES W/O COMPLICATION^7^34
 ;;^UTILITY(U,$J,358.4,290,0)
 ;;=EENT^9^34
 ;;^UTILITY(U,$J,358.4,291,0)
 ;;=ENDOCRINE/METABOLIC^10^34
 ;;^UTILITY(U,$J,358.4,292,0)
 ;;=GASTROENTEROLOGY^11^34
 ;;^UTILITY(U,$J,358.4,293,0)
 ;;=GENITOURINARY^12^34
 ;;^UTILITY(U,$J,358.4,294,0)
 ;;=HEMATOLOGY/ONCOLOGY^13^34
 ;;^UTILITY(U,$J,358.4,295,0)
 ;;=HISTORY & STATUS POST^14^34
 ;;^UTILITY(U,$J,358.4,296,0)
 ;;=INFECTIOUS DISEASE^15^34
 ;;^UTILITY(U,$J,358.4,297,0)
 ;;=INFLAMMATORY/INF LUNG DX^16^34
 ;;^UTILITY(U,$J,358.4,298,0)
 ;;=INTERSTITIAL DISEASE^17^34
 ;;^UTILITY(U,$J,358.4,299,0)
 ;;=MENTAL HEALTH^18^34
 ;;^UTILITY(U,$J,358.4,300,0)
 ;;=MUSCULOSKELETAL^19^34
 ;;^UTILITY(U,$J,358.4,301,0)
 ;;=NEUROLOGY^20^34
 ;;^UTILITY(U,$J,358.4,302,0)
 ;;=OBSTRUCTIVE AIRWAY DISEASE^21^34
 ;;^UTILITY(U,$J,358.4,303,0)
 ;;=ORAL CAVITY^22^34
 ;;^UTILITY(U,$J,358.4,304,0)
 ;;=OTHER REASONS^23^34
 ;;^UTILITY(U,$J,358.4,305,0)
 ;;=PAIN^24^34
 ;;^UTILITY(U,$J,358.4,306,0)
 ;;=PERSONAL HISTORY^25^34
 ;;^UTILITY(U,$J,358.4,307,0)
 ;;=PLEURAL DISEASE^26^34
 ;;^UTILITY(U,$J,358.4,308,0)
 ;;=PNEUMONIA^27^34
 ;;^UTILITY(U,$J,358.4,309,0)
 ;;=PULMONARY VASCULAR DISEASE^29^34
 ;;^UTILITY(U,$J,358.4,310,0)
 ;;=RESPIRATORY^30^34
 ;;^UTILITY(U,$J,358.4,311,0)
 ;;=SECONDARY DIABETES^31^34
 ;;^UTILITY(U,$J,358.4,312,0)
 ;;=SIGNS, SYMPTOMS, CONDITIONS^32^34
 ;;^UTILITY(U,$J,358.4,313,0)
 ;;=SLEEP DISORDERS^33^34
 ;;^UTILITY(U,$J,358.4,314,0)
 ;;=THROMBO EMBOLIC DISEASE^34^34
 ;;^UTILITY(U,$J,358.4,315,0)
 ;;=TUMOR^35^34
 ;;^UTILITY(U,$J,358.4,316,0)
 ;;=VASCULAR^36^34
 ;;^UTILITY(U,$J,358.4,317,0)
 ;;=PRE-OP/POST-OP/COUNSELING^28^34
 ;;^UTILITY(U,$J,358.4,318,0)
 ;;=E-CONSULTS^8^34
 ;;^UTILITY(U,$J,358.4,319,0)
 ;;=MD/NP/PA^1^35
 ;;^UTILITY(U,$J,358.4,320,0)
 ;;=NON-LIP^2^35
 ;;^UTILITY(U,$J,358.4,321,0)
 ;;=IMMUNIZATION^10^36
 ;;^UTILITY(U,$J,358.4,322,0)
 ;;=MEDICATION^12^36
 ;;^UTILITY(U,$J,358.4,323,0)
 ;;=ORTHO/JOINTS^6^36
 ;;^UTILITY(U,$J,358.4,324,0)
 ;;=RESPIRATORY SYSTEM^13^36
 ;;^UTILITY(U,$J,358.4,325,0)
 ;;=CRITICAL CARE/PULM/SEDATION^3^36
 ;;^UTILITY(U,$J,358.4,326,0)
 ;;=GI/GYN^7^36
 ;;^UTILITY(U,$J,358.4,327,0)
 ;;=NEURO/EYE/ENT^8^36
 ;;^UTILITY(U,$J,358.4,328,0)
 ;;=LACERATIONS^5^36
 ;;^UTILITY(U,$J,358.4,329,0)
 ;;=SKIN WOUNDS/BURNS^4^36
 ;;^UTILITY(U,$J,358.4,330,0)
 ;;=PSYCHIATRY^9^36
 ;;^UTILITY(U,$J,358.4,331,0)
 ;;=COMMON PROCEDURES^1^36
